GIT1, which inactivates ARF6 specifically, is highly expressed in several types of cancers, including breast, cervical, colon and liver (Yoo et al., 2012; Chan et al., 2014; Huang et al., 2014; Peng et al., 2014). This evidence concerns the gene ARF6 and cancer.